What is Selank?
Selank is a synthetic peptide based on tuftsin, a naturally occurring immune-related peptide. Much of its study has taken place in Russia, where related peptides have been used clinically.
Western clinical data is limited. It is not FDA-approved and is among the peptides under the 2026 compounding review.
How it is thought to work
Selank has been studied for effects on neurotransmitter systems and stress pathways, which is the basis for interest in calm and focus applications.
What the research shows
Available studies are mostly small or conducted outside large Western trial frameworks, so the evidence base is limited and a provider can put it in context.
We summarize published research and do not make therapeutic promises. A licensed provider can evaluate whether any therapy is appropriate for you. Treat any source promising guaranteed results with skepticism.
Studied uses
- Stress and anxiety-response research
- Focus and mental clarity
- Often discussed alongside Semax
Legal status in 2026
Selank is not FDA-approved and is among the peptides under federal review in 2026. No rule has changed yet, and it would remain prescription-only even if reclassified.
How to access Selank legitimately
A licensed provider can review suitability and, where permitted, prescribe through a licensed compounding pharmacy.
PeptideForward can match you with vetted telehealth providers who handle these therapies through legitimate channels. The eligibility check takes about five minutes and there is no cost to see if you are a candidate.
Frequently asked questions
Where was Selank developed? It was developed and studied largely in Russia. Western clinical data is limited.
Is it legal now? It is not approved. Where permitted it requires a prescription, and its compounding status is under 2026 review.
Does PeptideForward sell it? No. We are an education and matching service only.